Patent ID: 11872278
Assignee: MODERNATX, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 6:
7. The mRNA vaccine of claim 5, wherein the ionizable cationic lipid is a compound of Formula (I):, , and wherein
R1 is R″M′R′ or C5-20 alkenyl;
R2 and R3 are each independently selected from C1-14 alkyl and C2-14 alkenyl;
R4 is —(CH2)nQ, wherein Q is OH and n is selected from 3, 4, and 5;
M and M′ are each independently —OC(O)— or —C(O)O—;
R5, R6, and R7 are each H;
R′ is a linear C1-12 alkyl, or C1-12 alkyl substituted with C6-9 alkyl;
R″ is C3-14 alkyl;
m is selected from 5, 6, 7, 8, 9, 10, 11, 12, and 13.